Researchers have shown an innovative antibody delivery method could be an effective way to prevent and treat Ebola infection. They demonstrated that delivering a monoclonal antibody gene to a cell through a viral vector — a process that bypasses the need for the host to generate a natural immune response — provided up to 100-per-cent protection against infection in mice. The mice expressed the antibody for more than 300 days.